InvestorsHub Logo

rustydog62

02/23/15 8:38 PM

#5004 RE: nupapa #5003

Nupapa, "Biocept's blood-based diagnostic may be as effective in determining a patient's HR status as traditional tissue biopsy", which means that the MRX method is still light years ahead at detection of Cancer Cells.

If you really want to see great advancements on getting rid of Cancer cells for good, you should watch the new Vice show on HBO this Friday night. They are going to have a complete segment on it. It is going to stir the whole medical field a great bit.

Here is a short scientific segment on it just put out less than 2 months ago...

jim30jen

02/23/15 10:02 PM

#5005 RE: nupapa #5003

Nupapa, That study dealt with circulating cancer cells in the bloodstream, which is a very similar tact as Google-x has taken. MRX differs in that it detects conglomerations of cancer cells called tumors rather than free circulating cells. Also that study was about metastatic (cancer that has spread to or resurfaced in other parts of the body) breast cancers and determining the type of breast cancer as determined by hormone receptors. MRX could detect, locate and measure the tumor and depending on the bio marker of the NP determine the type. Wouldn't it then be a different cancer like if a breast cancer spread to the lungs wouldn't it then be lung cancer? No. Once the original diagnosis is "breast cancer", any and all future cancers in that patient are also breast cancer no matter where they show up.